Nisa Investment Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Nisa Investment Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,425	Closed	-$69	–	2374
2021 Q3	$69	Hold	3,425	–	–	﹤0.01%	1850
2021 Q2	$128	Hold	3,425	–	–	﹤0.01%	1582
2021 Q1	$88	Hold	3,425	–	–	﹤0.01%	1806
2020 Q4	$75K	Buy	3,425 +300	+10%	+$6.61K	﹤0.01%	1862
2020 Q3	$56K	Buy	3,125 +2,350	+303%	+$48.7K	﹤0.01%	1760
2020 Q2	$20K	Buy	775 +225	+41%	+$4.85K	﹤0.01%	1778
2020 Q1	$10K	Hold	550	–	–	﹤0.01%	1857
2019 Q4	$12K	Hold	550	–	–	﹤0.01%	1803
2019 Q3	$8K	Buy	550 +240	+77%	+$3.43K	﹤0.01%	1842
2019 Q2	$5K	Hold	310	–	–	﹤0.01%	1911
2019 Q1	$5K	Hold	310	–	–	﹤0.01%	1926
2018 Q4	$3K	Hold	310	–	–	﹤0.01%	1892
2018 Q3	$5K	Buy	+310	New	+$4.51K	﹤0.01%	1882

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Nisa Investment Advisors's DRNA Position: Q4 2021 in Review

Nisa Investment Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,425 shares — an estimated $69 sold.

Nisa Investment Advisors first reported a position in DRNA in Q3 2018 and held it in 13 quarters. The position peaked at $75K in Q4 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Nisa Investment Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Nisa Investment Advisors sold 3,425 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $69.
Nisa Investment Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2018 and held it in 13 quarters.
Nisa Investment Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $75K in Q4 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.